BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 38589358)

  • 21. Genome-wide association study identifies tumor anatomical site-specific risk variants for colorectal cancer survival.
    Labadie JD; Savas S; Harrison TA; Banbury B; Huang Y; Buchanan DD; Campbell PT; Gallinger SJ; Giles GG; Gunter MJ; Hoffmeister M; Hsu L; Jenkins MA; Lin Y; Ogino S; Phipps AI; Slattery ML; Steinfelder RS; Sun W; Van Guelpen B; Hua X; Figuieredo JC; Pai RK; Nassir R; Qi L; Chan AT; Peters U; Newcomb PA
    Sci Rep; 2022 Jan; 12(1):127. PubMed ID: 34996992
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diet- and Lifestyle-Based Prediction Models to Estimate Cancer Recurrence and Death in Patients With Stage III Colon Cancer (CALGB 89803/Alliance).
    Cheng E; Ou FS; Ma C; Spiegelman D; Zhang S; Zhou X; Bainter TM; Saltz LB; Niedzwiecki D; Mayer RJ; Whittom R; Hantel A; Benson A; Atienza D; Messino M; Kindler H; Giovannucci EL; Van Blarigan EL; Brown JC; Ng K; Gross CP; Meyerhardt JA; Fuchs CS
    J Clin Oncol; 2022 Mar; 40(7):740-751. PubMed ID: 34995084
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A genome-wide search for determinants of survival in 1926 patients with advanced colorectal cancer with follow-up in over 22,000 patients.
    Wills C; He Y; Summers MG; Lin Y; Phipps AI; Watts K; Law PJ; Al-Tassan NA; Maughan TS; Kaplan R; Houlston RS; Peters U; Newcomb PA; Chan AT; Buchanan DD; Gallinger S; Marchand LL; Pai RK; Shi Q; Alberts SR; Gray V; West HD; Escott-Price V; Dunlop MG; Cheadle JP
    Eur J Cancer; 2021 Dec; 159():247-258. PubMed ID: 34794066
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Responsible use of polygenic risk scores in the clinic: potential benefits, risks and gaps.
    Polygenic Risk Score Task Force of the International Common Disease Alliance
    Nat Med; 2021 Nov; 27(11):1876-1884. PubMed ID: 34782789
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Improving reporting standards for polygenic scores in risk prediction studies.
    Wand H; Lambert SA; Tamburro C; Iacocca MA; O'Sullivan JW; Sillari C; Kullo IJ; Rowley R; Dron JS; Brockman D; Venner E; McCarthy MI; Antoniou AC; Easton DF; Hegele RA; Khera AV; Chatterjee N; Kooperberg C; Edwards K; Vlessis K; Kinnear K; Danesh JN; Parkinson H; Ramos EM; Roberts MC; Ormond KE; Khoury MJ; Janssens ACJW; Goddard KAB; Kraft P; MacArthur JAL; Inouye M; Wojcik GL
    Nature; 2021 Mar; 591(7849):211-219. PubMed ID: 33692554
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lifestyle after colorectal cancer diagnosis in relation to recurrence and all-cause mortality.
    van Zutphen M; Boshuizen HC; Kenkhuis MF; Wesselink E; Geijsen AJMR; de Wilt JHW; van Halteren HK; Spillenaar Bilgen EJ; Keulen ETP; Janssen-Heijnen MLG; Breukink SO; Bours MJL; Kok DE; Winkels RM; Weijenberg MP; Kampman E; van Duijnhoven FJB
    Am J Clin Nutr; 2021 Jun; 113(6):1447-1457. PubMed ID: 33677488
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.
    Sung H; Ferlay J; Siegel RL; Laversanne M; Soerjomataram I; Jemal A; Bray F
    CA Cancer J Clin; 2021 May; 71(3):209-249. PubMed ID: 33538338
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A prospective study of the associations among fine particulate matter, genetic variants, and the risk of colorectal cancer.
    Chu H; Xin J; Yuan Q; Wu Y; Du M; Zheng R; Liu H; Wu S; Zhang Z; Wang M
    Environ Int; 2021 Feb; 147():106309. PubMed ID: 33338681
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Novel Genetic and Epigenetic Biomarkers of Prognostic and Predictive Significance in Stage II/III Colorectal Cancer.
    Luo XJ; Zhao Q; Liu J; Zheng JB; Qiu MZ; Ju HQ; Xu RH
    Mol Ther; 2021 Feb; 29(2):587-596. PubMed ID: 33333293
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Combined Utility of 25 Disease and Risk Factor Polygenic Risk Scores for Stratifying Risk of All-Cause Mortality.
    Meisner A; Kundu P; Zhang YD; Lan LV; Kim S; Ghandwani D; Pal Choudhury P; Berndt SI; Freedman ND; Garcia-Closas M; Chatterjee N
    Am J Hum Genet; 2020 Sep; 107(3):418-431. PubMed ID: 32758451
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tutorial: a guide to performing polygenic risk score analyses.
    Choi SW; Mak TS; O'Reilly PF
    Nat Protoc; 2020 Sep; 15(9):2759-2772. PubMed ID: 32709988
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Progress in cancer survival, mortality, and incidence in seven high-income countries 1995-2014 (ICBP SURVMARK-2): a population-based study.
    Arnold M; Rutherford MJ; Bardot A; Ferlay J; Andersson TM; Myklebust TÅ; Tervonen H; Thursfield V; Ransom D; Shack L; Woods RR; Turner D; Leonfellner S; Ryan S; Saint-Jacques N; De P; McClure C; Ramanakumar AV; Stuart-Panko H; Engholm G; Walsh PM; Jackson C; Vernon S; Morgan E; Gavin A; Morrison DS; Huws DW; Porter G; Butler J; Bryant H; Currow DC; Hiom S; Parkin DM; Sasieni P; Lambert PC; Møller B; Soerjomataram I; Bray F
    Lancet Oncol; 2019 Nov; 20(11):1493-1505. PubMed ID: 31521509
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Towards clinical utility of polygenic risk scores.
    Lambert SA; Abraham G; Inouye M
    Hum Mol Genet; 2019 Nov; 28(R2):R133-R142. PubMed ID: 31363735
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Predictive value of single-nucleotide polymorphism signature for recurrence in localised renal cell carcinoma: a retrospective analysis and multicentre validation study.
    Wei JH; Feng ZH; Cao Y; Zhao HW; Chen ZH; Liao B; Wang Q; Han H; Zhang J; Xu YZ; Li B; Wu JT; Qu GM; Wang GP; Liu C; Xue W; Liu Q; Lu J; Li CX; Li PX; Zhang ZL; Yao HH; Pan YH; Chen WF; Xie D; Shi L; Gao ZL; Huang YR; Zhou FJ; Wang SG; Liu ZP; Chen W; Luo JH
    Lancet Oncol; 2019 Apr; 20(4):591-600. PubMed ID: 30880070
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Combinations of single nucleotide polymorphisms identified in genome-wide association studies determine risk for colorectal cancer.
    Xin J; Du M; Gu D; Ge Y; Li S; Chu H; Meng Y; Shen H; Zhang Z; Wang M
    Int J Cancer; 2019 Nov; 145(10):2661-2669. PubMed ID: 30859566
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The personal and clinical utility of polygenic risk scores.
    Torkamani A; Wineinger NE; Topol EJ
    Nat Rev Genet; 2018 Sep; 19(9):581-590. PubMed ID: 29789686
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Defining an Optimal Cut-Point Value in ROC Analysis: An Alternative Approach.
    Unal I
    Comput Math Methods Med; 2017; 2017():3762651. PubMed ID: 28642804
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Common genetic variation and survival after colorectal cancer diagnosis: a genome-wide analysis.
    Phipps AI; Passarelli MN; Chan AT; Harrison TA; Jeon J; Hutter CM; Berndt SI; Brenner H; Caan BJ; Campbell PT; Chang-Claude J; Chanock SJ; Cheadle JP; Curtis KR; Duggan D; Fisher D; Fuchs CS; Gala M; Giovannucci EL; Hayes RB; Hoffmeister M; Hsu L; Jacobs EJ; Jansen L; Kaplan R; Kap EJ; Maughan TS; Potter JD; Schoen RE; Seminara D; Slattery ML; West H; White E; Peters U; Newcomb PA
    Carcinogenesis; 2016 Jan; 37(1):87-95. PubMed ID: 26586795
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The PLCO Cancer Screening Trial: Background, Goals, Organization, Operations, Results.
    Gohagan JK; Prorok PC; Greenwald P; Kramer BS
    Rev Recent Clin Trials; 2015; 10(3):173-80. PubMed ID: 26238115
    [TBL] [Abstract][Full Text] [Related]  

  • 40. UK biobank: an open access resource for identifying the causes of a wide range of complex diseases of middle and old age.
    Sudlow C; Gallacher J; Allen N; Beral V; Burton P; Danesh J; Downey P; Elliott P; Green J; Landray M; Liu B; Matthews P; Ong G; Pell J; Silman A; Young A; Sprosen T; Peakman T; Collins R
    PLoS Med; 2015 Mar; 12(3):e1001779. PubMed ID: 25826379
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.